ProteoMediX AG (ProteoMediX) is a medical diagnostic company. The company identifies and develops biomarkers for the early detection of cancer and the personalized treatment. It offers products for prostate cancer detection,
‘ADC Therapeutics SA – Product Pipeline Review – 2016’, provides an overview of the ADC Therapeutics SA’s pharmaceutical research and development focus.